Australia
Croda started operations in Australia in 1968, attracted by the availability of high-quality wool grease. We have two operating sites in Australia; one located in Parramatta, a commercial suburb of Sydney in New South Wales, providing technical sales, market development and warehousing for customers in Australia, New Zealand and the Pacific Islands
Australia is also home to a manufacturing site for our seed enhancement business, Incotec Australia, at Carrum Downs in Melbourne.
Both businesses operate under the legal entity of Croda Australia Pty Ltd. Our Australian team has frequent contact with local charities and events, participating in community activities through the Croda 1% Club.
Parramatta
NSW 2150
Australia
Tel:+61 2 8849 0397
Email: sales.australia@croda.com
Carrum Downs
VIC 3201
Australia
Tel:+61 3 9770 8449
Email: incotec.australia@croda.com
Australia is also home to a manufacturing site for our seed enhancement business, Incotec Australia, at Carrum Downs in Melbourne.
Both businesses operate under the legal entity of Croda Australia Pty Ltd. Our Australian team has frequent contact with local charities and events, participating in community activities through the Croda 1% Club.
Croda Australia
Suite 2, Level 5, 111 Phillip StreetParramatta
NSW 2150
Australia
Tel:+61 2 8849 0397
Email: sales.australia@croda.com
Incotec Australia
7 Gateway DriveCarrum Downs
VIC 3201
Australia
Tel:+61 3 9770 8449
Email: incotec.australia@croda.com
About us
We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.
Where we operate
Every day our global team, across 37 countries, work together to inspire our customers.
Further reading
U.S. Government to support expansion of Croda lipid systems capability
Today we announce a joint investment with the U.S. government to expand our U.S manufacturing capacity for lipid systems used in novel therapeutic drugs, such as mRNA vaccines
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...